Research vessel Resilience charts course to the future of marine research

Dedication of the new hybrid-electric vessel was celebrated by laboratory, state, tribal and federal officials

2024-09-06

(Press-News.org) SEQUIM, Wash.—Officials gathered at the Sequim campus of the Department of Energy’s Pacific Northwest National Laboratory today to dedicate DOE’s first hybrid-electric research vessel, RV Resilience.

The event marks the start of a new era of marine energy research at PNNL-Sequim, part of DOE’s Office of Science national laboratory system and Resilience’s new home port. Speakers at the dedication included U.S. Sen. Maria Cantwell, U.S. Rep. Derek Kilmer, Washington State Rep. Steve Tharinger and representatives from DOE and PNNL.

“DOE is focused on clean energy solutions. The RV Resilience enables us to accelerate the development and deployment of novel marine energy technologies from testing at the bench scale to early demonstration under real ocean operating conditions,” said Geri Richmond, DOE’s undersecretary for science and innovation. “Demand for these technologies is likely to increase in the coming years, unlocking opportunities for ocean science and maritime industries equipped to explore new applications for marine energy research that will help power the blue economy.”

Richmond’s chief of staff, Ariel Marshall, spoke on her behalf at the dedication ceremony.

The 50-foot research vessel will allow researchers to transport and install large equipment in Sequim Bay, such as demonstration-scale marine energy devices. These devices will help accelerate marine energy testing and support new partnerships with industry developers. In addition to reducing carbon emissions, the hybrid-electric vessel is nearly silent when operated in fully electric mode. This minimizes noise pollution for marine wildlife and enables more sensitive acoustic measurements during research operations.

“RV Resilience represents DOE’s and PNNL’s commitment to demonstrating how innovative approaches, like the design and construction of this unique hybrid vessel, can advance the nation’s quest for clean energy,” said Laboratory Director Steve Ashby.

The RV Resilience can operate on diesel engines or in a completely electric mode using onboard battery banks. These batteries can be charged with the diesel engines, at any marina or through a rapid charging station at the PNNL-Sequim dock.

The RV Resilience was made possible with support from DOE’s Office of Energy Efficiency and Renewable Energy and its Water Power Technologies Office. It will be managed and operated by researchers at PNNL-Sequim—a regional hub for marine energy research, development and testing—and enables research operations in nearby Sequim Bay.

“We’re exploring the potential of marine energy by conducting world-leading coastal and oceanographic science and research,” said Alejandro Moreno, associate principal deputy assistant secretary for EERE. “This new hybrid research vessel enables that work with fewer emissions and less impact on the ocean’s wildlife."

The RV Resilience is the latest in a series of investments that will grow PNNL’s capabilities in marine technology research to continue advancing renewable energy, climate resilience and national security. These planned investments include a pre-permitted marine testing site, an underwater cabled array connecting at-sea devices to shore facilities and an onshore microgrid and battery storage system.

Combined with the RV Resilience and a host of new onshore laboratory facilities, these capabilities will enable PNNL-Sequim to support DOE’s marine energy mission, including supporting the development of offshore wind and tidal energy, as well as marine carbon dioxide removal.

RV Resilience was built by Snow & Company in Seattle, Wash. To learn more about vessel specifications, visit PNNL’s website.

END

ELSE PRESS RELEASES FROM THIS DATE:

Mayo Clinic study finds dysfunctional white blood cells linked to heightened melanoma risk

2024-09-06

ROCHESTER, Minn. — About 8 to 10 million Americans over age 40 have an overabundance of cloned white blood cells, or lymphocytes, that hamper their immune systems. Although many who have this condition — called monoclonal B-cell lymphocytosis (MBL) — do not experience any symptoms, a new study shows they may have an elevated risk for several health complications, including melanoma, a form of skin cancer. The findings, by Mayo Clinic researchers, are published in a new paper in the Journal ...

100x improvement in sight seen after gene therapy trial

2024-09-06

PHILADELPHIA— The vision of people with a rare inherited condition that causes them to lose much of their sight early in childhood was 100 times better after they received gene therapy to address the genetic mutation causing it. Some patients even experienced a 10,000-fold improvement in their vision after receiving the highest dose of the therapy, according to researchers from the Perelman School of Medicine at the University of Pennsylvania who co-led the clinical trial published in The Lancet. “That 10,000-fold improvement ...

Gene therapy restores vision in first-ever trial for rare, inherited blindness

2024-09-06

After the treatment, one patient saw her first star. Another saw snowflakes for the first time. Other patients were newly able to navigate outside of the home or to read the labels on their child’s Halloween candy. The cause of these seemingly miraculous improvements? A gene therapy developed by University of Florida scientists, which restored useful vision to most patients with the rare, inherited blindness known as Leber congenital amaurosis type I, or LCA1, in a small trial. Those who received the highest dose of the gene therapy saw up to a 10,000-fold improvement ...

FAMU-FSU College of Engineering researchers examine how drought and water volume affect nutrients in Apalachicola River

2024-09-06

Near the Florida-Georgia border, the Chattahoochee and Flint rivers meet and become the Apalachicola River, which carries freshwater and nutrients downstream to the Apalachicola Bay. New research led by FAMU-FSU College of Engineering Assistant Professor Ebrahim Ahmadisharaf examined how drought and water volume in the Lower Apalachicola River watershed affect nitrogen and phosphorous, crucial nutrients for a healthy aquatic ecosystem. The study was published in Water Research. “In watershed systems like this, that are subject to regulations upstream, knowing how the ecosystem reacts to changes helps us manage it effectively,” said Ahmadisharaf, ...

Making baby food safer

2024-09-06

Rice and spinach are staples for babies’ and young children’s diets, but toxic metals and metalloids found in those foods can cause severe health impacts. In particular, heavy metals such as cadmium, lead, mercury, and metalloid arsenic could delay brain development in babies and young children. In new research published in the academic journal Environmental Geochemistry and Health, University of Delaware scientists have found that flooded rice fields tend to contain higher amounts of arsenic and lower amounts of cadmium. The drier those rice fields are, the lower the amounts of arsenic and the higher the amounts of cadmium. However, the higher cadmium is lower ...

Saline nasal drops reduce the duration of the common cold in young children by two days

2024-09-06

Using hypertonic saline nasal drops can reduce the length of the common cold in children by two days, according to a study that will be presented at the European Respiratory Society (ERS) Congress in Vienna, Austria [1]. They can also reduce the onward transmission of colds to family members. The results of the ELVIS-Kids randomised controlled trial were presented by Professor Steve Cunningham from Child Life and Health, University of Edinburgh, UK. He said: “Children have up to 10 to 12 upper respiratory tract infections, what we refer to as colds, per year, which ...

New RSV vaccine for older adults can result in individual and societal cost savings, benefits

2024-09-05

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research. The study conducted by researchers at the University of Michigan and the U.S. Centers for Disease Control and Prevention and published in the journal Vaccine, evaluated newly approved RSV vaccines: Arexvy, manufactured by GSK, and Abrysvo, manufactured by Pfizer. The study did not include a third approved vaccine, Moderna's mRESVIA. The vaccines are now available to adults 60 and older. The CDC recommends a single ...

Research news from the Ecological Society of America

2024-09-05

The Ecological Society of America (ESA) presents a roundup of seven research articles recently published across its esteemed journals. Widely recognized for fostering innovation and advancing ecological knowledge, ESA’s journals consistently feature illuminating and impactful studies. This compilation of papers explores the impact of rising temperatures on pathogens, dynamics of predatory seabirds and their penguin prey in Antarctica, factors determining the speed of coral reef recovery from disturbance and more. From Ecology: Some pathogens can’t ...

AI unlocks new path to personalized cancer treatments

2024-09-05

Researchers at Auburn University, in collaboration with scientists from the University of Basel and ETH Zurich, have made a groundbreaking advance in the fight against cancer. The team, led by Dr. Rafael Bernardi, Associate Professor of Biophysics in the Department of Physics, has developed a novel approach integrating artificial intelligence (AI) with molecular dynamics simulations and network analysis to enhance the prediction of binding sites on the PD-L1 protein. This breakthrough promises to accelerate the development ...

ResearchGate and Mary Ann Liebert, Inc. announce journal home partnership for open access journals

2024-09-05

ResearchGate, the professional network for researchers, and Mary Ann Liebert, Inc., a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services, are pleased to announce a new partnership through ResearchGate’s innovative Journal Home offering. The partnership covers five Mary Ann Liebert, Inc. open access journals spanning the health and medical sciences. All backfile content and all new articles published with ...

Research vessel Resilience charts course to the future of marine research

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: